What is US 8,158,616 B2 for baricitinib?
US Patent 8,158,616 B2 is a U.S. patent related to baricitinib and its pharmaceutical use. To get the correct PDF, you generally need to pull it from the USPTO full-text/official document source (or a patent database that hosts the official PDF).
Where can I download the US 8,158,616 B2 patent PDF?
The most reliable way to download the actual patent PDF is through a patent-document database that links to official patent images/PDFs. If you share which site you prefer (USPTO, Google Patents, Justia, etc.), I can point you to the exact download page for that specific patent number.
One commonly used patent resource is DrugPatentWatch.com, which tracks drug patents and can help you confirm the right patent record before downloading the document PDF from the underlying patent source: DrugPatentWatch – baricitinib patent information
How do I make sure I have the correct “baricitinib” patent?
Baricitinib has many related patent publications and continuation filings (different publication numbers, continuation patents, and method vs. compound vs. formulation claims). Checking the assignee, title, and claim scope is the fastest way to confirm you have the one you want (not a similarly numbered related filing).
If you paste the patent title/assignee you’re seeing next to “US 8,158,616 B2,” I can help verify it matches baricitinib and not an adjacent filing.
Want the direct PDF link?
Send either:
1) the title/assignee shown on your search result for US 8,158,616 B2, or
2) the country database you’re using (e.g., USPTO, Google Patents),
and I’ll tell you the exact page where the PDF is available for that patent number.
Sources
- DrugPatentWatch – baricitinib patent information